Self-administered intranasal medication to terminate supraventricular tachycardia
T Campbell, S Kumar - The Lancet, 2023 - thelancet.com
Comment 82 www. thelancet. com Vol 402 July 8, 2023 initial intravenous medical therapy
does not terminate an event, or for those who are haemodynamically compromised, direct …
does not terminate an event, or for those who are haemodynamically compromised, direct …
[引用][C] Self-administered intranasal medication to terminate supraventricular tachycardia
T Campbell, S Kumar - Lancet (London, England), 2023 - pubmed.ncbi.nlm.nih.gov
Self-administered intranasal medication to terminate supraventricular tachycardia Self-administered
intranasal medication to terminate supraventricular tachycardia Lancet. 2023 Jul 8;402(10396):81-83 …
intranasal medication to terminate supraventricular tachycardia Lancet. 2023 Jul 8;402(10396):81-83 …
[引用][C] Self-administered intranasal medication to terminate supraventricular tachycardia.
T Campbell, S Kumar - Lancet (London, England), 2023 - europepmc.org
Self-administered intranasal medication to terminate supraventricular tachycardia. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
[引用][C] Self-administered intranasal medication to terminate supraventricular tachycardia
TG Campbell, S Kumar - 2023 - wslhd.intersearch.com.au
WSLHD Digital Repository: Self-administered intranasal medication to terminate supraventricular
tachycardia WSLHD Skip navigation DSpace logo Home Browse Communities & Collections Browse …
tachycardia WSLHD Skip navigation DSpace logo Home Browse Communities & Collections Browse …